Venus Remedies Ltd. share price target and research reports

Name: Latest research reports of Venus Remedies Ltd. authored by Keynotes Financial Opiniery and published by - Trendlyne research reports.
Item: Venus Remedies Ltd.
Rating: 5
Author: Keynotes Financial Opiniery

Latest analyst research reports with target prices and PDF download for VENUSREM, BSE:526953 Venus Remedies Ltd.

Search Inside the pdf :

Venus Remedies Ltd.

16 Aug 2023

433.35

1.77%

Indian Pharmaceutical company

Buy: Venus Remedies Ltd.

Keynotes Financial Opiniery

The Indian pharmaceutical and healthcare sector is anticipated to register a growth of 8-10% in FY24. Pharmaceutical businesses will continue to reassess the risk of their dependencies on global supply chains, given the resurfacing of the COVID-19 pandemic in some nations and the recent Russia-Ukraine war that has significantly impacted the operations of pharmaceutical companies globally.

Venus Remedies Ltd. has gained 28.36% in the last 1 Month

Is Venus Remedies Ltd. worth buying?

65 Votes:

Buy 73.85%

Sell 16.92%

Hold 9.23%